Published guidance, NICE advice and quality standards | Guidance

Showing 621 to 630 of 2422

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Looked-after children and young people	NG205	20 October 2021	20 October 2021
Secukinumab for treating moderate to severe plaque psoriasis in children and young people	TA734	7 October 2021	7 October 2021
Baloxavir marboxil for treating acute uncomplicated influenza (terminated appraisal)	TA732	6 October 2021	6 October 2021
Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia	TA733	6 October 2021	6 October 2021
DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography	MTG60	4 October 2021	4 October 2021
Avapritinib for treating unresectable or metastatic gastrointestinal stromal tumours (terminated appraisal)	TA730	29 September 2021	29 September 2021
Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal)	TA731	29 September 2021	29 September 2021
Daratumumab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)	TA726	22 September 2021	22 September 2021
Isatuximab with carfilzomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)	TA727	22 September 2021	22 September 2021
Midostaurin for treating advanced systemic mastocytosis	TA728	22 September 2021	22 September 2021